Nabholtz, J M <br/><br/>
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  May 1999 
 - 1413-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1999.17.5.1413  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Antineoplastic Agents--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Disease Progression<br/>Docetaxel<br/>Drug Administration Schedule<br/>Drug Resistance, Neoplasm<br/>Female<br/>Health Status<br/>Humans<br/>Middle Aged<br/>Mitomycins--administration & dosage<br/>Neutropenia--chemically induced<br/>Paclitaxel--administration & dosage<br/>Patient Compliance<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Survival Analysis<br/>Taxoids<br/>Thrombocytopenia--chemically induced<br/>Vinblastine--administration & dosage